BPC-157
Preclinical investigation of tissue response, vascular signaling and repair pathways.


Vial concentration
BPC-157
5 mgThis is a clinician-reviewed research peptide. Pricing is provided as part of an approved, personalized plan after your assessment is reviewed.
Not sure where to start?
Discover what may fit your goals — a short, personalized Regenexa Assessment.
Take Your Assessment →- 🔒 Secure & encrypted checkout
- 📦 Fast, discreet worldwide shipping
- 🧪 Pharmaceutical-grade quality
- 🔬 Research use only
Synthetic fragment derived from a gastric-protective protein; studied for promoting angiogenesis (via VEGF/FAK-paxillin pathway signaling in animal models) and modulating growth-factor expression in tendon, ligament and gut tissue.
Receptors
Half-life: Not well established in human pharmacokinetic literature; animal data suggests a short half-life requiring frequent dosing.
Ask Regenexa AI about BPC-157
Get plain-language answers on mechanism, evidence and how it compares to other peptides — grounded in Regenexa's verified data.
“Is BPC-157 proven to heal tendons in humans?”Ask Regenexa AI →
BPC-157 + TB-500
TB-500